Hence, to evaluate the clinical significance of PVT1 expression changes alone, we conducted Kaplan–Meier survival analysis using KM plotter (Gyorffy et al, 2012) in TCGA datasets that included all ovarian cancer patients with a best cutoff analysis (Nagy et al, 2018). The gene discussed is PVT1; the disease is ovarian cancer.